Advocacy intelligence hub — real-time data for patient organizations
City of Hope Medical Center — PHASE2
Dana-Farber Cancer Institute — PHASE4
Zhejiang Haichang Biotech Co., Ltd. — PHASE2
City of Hope Medical Center — PHASE2
Abramson Cancer Center at Penn Medicine — NA
Sun Yat-sen University — NA
Gustave Roussy, Cancer Campus, Grand Paris — NA
Erasmus Medical Center — NA
Menoufia University — NA
Bristol-Myers Squibb — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Acquired cystic disease-associated renal cell carcinoma news →
Bo Shen, MD
Clevland Clinic
📍 CLEVELAND, OH
Eric Jonasch, MD, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Toni K Choueiri, MD, M.D
Dana-Farber Cancer Institute
📍 BOSTON, MA
Daniel George, MD
Duke University
Giuseppe Procopio, MD, R. Ph
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
📍 RAHWAY, NJ
Matthew D Galsky
City of Hope Comprehensive Cancer Center
📍 Duarte, California
View all Acquired cystic disease-associated renal cell carcinoma specialists →